These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 6335905

  • 1. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis.
    Malluche HH, Faugere MC, Fanti P, Price PA.
    Kidney Int; 1984 Dec; 26(6):869-74. PubMed ID: 6335905
    [Abstract] [Full Text] [Related]

  • 2. Serum bone Gla-protein in renal osteodystrophy: comparison with bone histomorphometry.
    Charhon SA, Delmas PD, Malaval L, Chavassieux PM, Arlot M, Chapuy MC, Meunier PJ.
    J Clin Endocrinol Metab; 1986 Oct; 63(4):892-7. PubMed ID: 3488998
    [Abstract] [Full Text] [Related]

  • 3. Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation.
    Epstein S, Traberg H, Raja R, Poser J.
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1253-6. PubMed ID: 3889031
    [Abstract] [Full Text] [Related]

  • 4. Bisphosphonate kinetics in patients undergoing continuous ambulatory peritoneal dialysis: relations to dynamic bone histomorphometry, osteocalcin and parathyroid hormone.
    Joffe P, Hyldstrup L, Heaf JG, Pødenphant J, Henriksen JH.
    Am J Nephrol; 1992 Jun; 12(6):419-24. PubMed ID: 1292341
    [Abstract] [Full Text] [Related]

  • 5. Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis.
    Gerakis A, Hutchison AJ, Apostolou T, Freemont AJ, Billis A.
    Nephrol Dial Transplant; 1996 Dec; 11(12):2430-8. PubMed ID: 9017618
    [Abstract] [Full Text] [Related]

  • 6. Bone GLA protein in predialysis chronic renal failure. Effects of 1,25(OH)2D3 administration in a long-term follow-up.
    Coen G, Mazzaferro S, Bonucci E, Taggi F, Ballanti P, Bianchi AR, Donato G, Massimetti C, Smacchi A, Cinotti GA.
    Kidney Int; 1985 Nov; 28(5):783-90. PubMed ID: 3878905
    [Abstract] [Full Text] [Related]

  • 7. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.
    Ureña P, Hruby M, Ferreira A, Ang KS, de Vernejoul MC.
    J Am Soc Nephrol; 1996 Mar; 7(3):506-12. PubMed ID: 8704118
    [Abstract] [Full Text] [Related]

  • 8. [Osteocalcin in chronic hemodialysis patients as an additional parameter in the diagnosis of advanced secondary hyperparathyroidism].
    Motz W.
    Acta Med Austriaca; 1989 Mar; 16(1):8-12. PubMed ID: 2785325
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM, Ostertag A, Schulten K, Schulz W, Jehle DR, Stracke S, Fiedler R, Deuber HJ, Keller F, Boehm BO, Baylink DJ, Mohan S.
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Changes in plasma bone GLA protein during treatment of bone disease.
    Deftos LJ, Parthemore JG, Price PA.
    Calcif Tissue Int; 1982 Mar; 34(2):121-4. PubMed ID: 6805917
    [Abstract] [Full Text] [Related]

  • 14. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)].
    Offermann G, Schaefer K, Schulz A, Delling G.
    Klin Wochenschr; 1976 Jul 01; 54(13):625-32. PubMed ID: 940299
    [Abstract] [Full Text] [Related]

  • 15. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.
    Fletcher S, Jones RG, Rayner HC, Harnden P, Hordon LD, Aaron JE, Oldroyd B, Brownjohn AM, Turney JH, Smith MA.
    Nephron; 1997 Jul 01; 75(4):412-9. PubMed ID: 9127327
    [Abstract] [Full Text] [Related]

  • 16. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
    Coen G, Ballanti P, Bonucci E, Calabria S, Centorrino M, Fassino V, Manni M, Mantella D, Mazzaferro S, Napoletano I, Sardella D, Taggi F.
    Nephrol Dial Transplant; 1998 Sep 01; 13(9):2294-302. PubMed ID: 9761512
    [Abstract] [Full Text] [Related]

  • 17. Spectrum of renal osteodystrophy in children on continuous ambulatory peritoneal dialysis.
    Yalçinkaya F, Ince E, Tümer N, Ensari A, Ozkaya N.
    Pediatr Int; 2000 Feb 01; 42(1):53-7. PubMed ID: 10703235
    [Abstract] [Full Text] [Related]

  • 18. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G, Bianchi ML, Valenti G.
    Clin Nephrol; 1984 Dec 01; 22(6):279-83. PubMed ID: 6525771
    [Abstract] [Full Text] [Related]

  • 19. Clinical significance of serum bone Gla protein and urinary gamma-Gla as biochemical markers in primary hyperparathyroidism.
    Yoneda M, Takatsuki K, Oiso Y, Takano T, Kurokawa M, Ota A, Tomita A, Ohno T, Okano K, Kanazawa T.
    Endocrinol Jpn; 1986 Feb 01; 33(1):89-94. PubMed ID: 3487445
    [Abstract] [Full Text] [Related]

  • 20. Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.
    Coen G, Ballanti P, Balducci A, Grandi F, Manni M, Mantella D, Pierantozzi A, Ruggeri M, Sardella D, Sorbo G, Bonucci E.
    Am J Kidney Dis; 2006 Jul 01; 48(1):106-13. PubMed ID: 16797392
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.